117 related articles for article (PubMed ID: 9608656)
41. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
42. Simian immunodeficiency viruses (SIVs) from eastern and southern Africa: detection of a SIVagm variant from a chacma baboon.
van Rensburg EJ; Engelbrecht S; Mwenda J; Laten JD; Robson BA; Stander T; Chege GK
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1809-14. PubMed ID: 9680146
[TBL] [Abstract][Full Text] [Related]
43. Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection.
Gueye A; Diop OM; Ploquin MJ; Kornfeld C; Faye A; Cumont MC; Hurtrel B; Barré-Sinoussi F; Müller-Trutwin MC
J Med Primatol; 2004 Apr; 33(2):83-97. PubMed ID: 15061721
[TBL] [Abstract][Full Text] [Related]
44. Genetic variation of the SIVagm transmembrane glycoprotein in naturally and experimentally infected primates.
Fomsgaard A; Johnson PR; London WT; Hirsch VM
AIDS; 1993 Aug; 7(8):1041-7. PubMed ID: 8397939
[TBL] [Abstract][Full Text] [Related]
45. Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.
Steidl S; Stitz J; Schmitt I; König R; Flory E; Schweizer M; Cichutek K
Virology; 2002 Sep; 300(2):205-16. PubMed ID: 12350351
[TBL] [Abstract][Full Text] [Related]
46. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.
Norley SG; Kraus G; Ennen J; Bonilla J; König H; Kurth R
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9067-71. PubMed ID: 2247482
[TBL] [Abstract][Full Text] [Related]
47. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host.
Beer B; Denner J; Brown CR; Norley S; zur Megede J; Coulibaly C; Plesker R; Holzammer S; Baier M; Hirsch VM; Kurth R
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):210-20. PubMed ID: 9665497
[TBL] [Abstract][Full Text] [Related]
48. Construction of gag-chimeric viruses between HIV-1 and SIVmac that are capable of productive multi-cycle infection.
Kamada K; Yoshida A; Khamsri B; Piroozmand A; Yamashita T; Uchiyama T; Fujita M; Adachi A
Microbes Infect; 2006 Apr; 8(4):1075-81. PubMed ID: 16520079
[TBL] [Abstract][Full Text] [Related]
49. Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: evidence for distinct levels of restriction in primary macrophages and a T-cell line.
Kim SS; You XJ; Harmon ME; Overbaugh J; Fan H
J Virol; 2001 Mar; 75(5):2288-300. PubMed ID: 11160732
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of HIV/SIV replication by dominant negative Gag mutants.
Shimano R; Inubushi R; Oshima Y; Adachi A
Virus Genes; 1999; 18(3):197-201. PubMed ID: 10456787
[TBL] [Abstract][Full Text] [Related]
51. Functional analysis of vif genes derived from various primate immunodeficiency viruses.
Yamamoto Y; Saito Y; Iida S; Asano J; Sone S; Adachi A
Virus Genes; 1997; 14(3):195-200. PubMed ID: 9311564
[TBL] [Abstract][Full Text] [Related]
52. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
53. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
Hoshikawa N; Kojima A; Yasuda A; Takayashiki E; Masuko S; Chiba J; Sata T; Kurata T
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
[TBL] [Abstract][Full Text] [Related]
54. Construction and characterization of a chimeric virus (BIV/HIV-1) carrying the bovine immunodeficiency virus gag-pol gene.
Chen G; Wang S; Xiong K; Wang J; Ye T; Dong W; Wang Q; Chen Q; Geng Y; Wood C; Zeng Y
AIDS; 2002 Jan; 16(1):123-5. PubMed ID: 11741171
[TBL] [Abstract][Full Text] [Related]
55. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
Rizvi TA; Schmidt RD; Lew KA
Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
[TBL] [Abstract][Full Text] [Related]
56. A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.
Someya K; Xin KQ; Matsuo K; Okuda K; Yamamoto N; Honda M
J Virol; 2004 Sep; 78(18):9842-53. PubMed ID: 15331719
[TBL] [Abstract][Full Text] [Related]
57. Isolation and characterization of simian immunodeficiency virus from African white-crowned mangabey monkeys (Cercocebus torquatus lunulatus).
Tomonaga K; Katahira J; Fukasawa M; Hassan MA; Kawamura M; Akari H; Miura T; Goto T; Nakai M; Suleman M
Arch Virol; 1993; 129(1-4):77-92. PubMed ID: 8470959
[TBL] [Abstract][Full Text] [Related]
58. Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.
Morikawa Y; Goto T; Yasuoka D; Momose F; Matano T
J Virol; 2007 Sep; 81(18):9911-21. PubMed ID: 17609278
[TBL] [Abstract][Full Text] [Related]
59. SIVagm infection of its natural African green monkey host.
Norley SG
Immunol Lett; 1996 Jun; 51(1-2):53-8. PubMed ID: 8811345
[TBL] [Abstract][Full Text] [Related]
60. Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation.
Allan JS; Whitehead EM; Strout K; Short M; Kanda P; Hart TK; Bugelski PJ
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2011-20. PubMed ID: 1493051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
